We report a case of acromegaly diagnosed in the second trimester of pregnancy. Bromocriptine (7.5 mg per day) corrected visual field defects and suppressed prolactin secretion but did not reduce fasting growth hormone levels. We propose that suppression of physiologic lactotroph hyperplasia by bromocriptine may permit noninvasive management of pituitary adenomas during pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9378(90)91178-f | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!